3-羟基-4-甲基-2-硝基苯甲酸甲酯 | 71788-49-3

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 3-羟基-4-甲基-2-硝基苯甲酸甲酯
• 英文名称: methyl 3-hydroxy-4-methyl-2-nitrobenzoate
• CAS: 71788-49-3
• 化学式: C₉H₉NO₅
• 分子量: 211.174
• InChiKey: LTGNNMNPRYIBRG-UHFFFAOYSA-N

物化性质

• 沸点：
  327.6±37.0 °C(Predicted)
• 密度：
  1.372±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.2
• 重原子数：
  15
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.22
• 拓扑面积：
  92.4
• 氢给体数：
  1
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  3-羟基-4-甲基-2-硝基苯甲酸甲酯 在 palladium on activated charcoal 盐酸 、 氢气 、 sodium methylate 、 silica gel 、 氢气 、 对甲苯磺酸 、 methyloxirane 、 肼 、 亚硝酸异戊酯 作用下， 以 苯 为溶剂， 反应 87.67h， 生成 3,6,9-trimethyl-2,3-dihydronaphtho<1,8-bc>pyran-3-ol
  参考文献：
  名称：

  苯并炔的分子内狄尔斯-阿尔德反应对甘露酮E的全合成

  摘要：

  取代的苯并炔分子会被附着的呋喃部分分子内捕获，并且这种反应已用于合成天然存在的邻萘甲醌一甘露酮E。

  DOI：

  10.1016/s0040-4039(01)92370-6
• 作为产物：
  描述：

  3-甲氧基-4-甲基-2-硝基苯甲酸 在 吡啶盐酸盐 作用下， 生成 3-羟基-4-甲基-2-硝基苯甲酸甲酯
  参考文献：
  名称：

  Angyal et al., Journal of the Chemical Society, 1957, p. 1592,1599

  摘要：

  DOI：

文献信息

• Herbicides
  申请人：RHONE-POULENC AGRICULTURE LTD.

  公开号：EP0918056A1

  公开（公告）日：1999-05-26

  The invention relates to 4-aroylisoxazole derivatives of formula (Ia) or to 2-cyano-1,3-dione derivatives of formula (Ib):    wherein R, R1, R2, X, Y and Z are as defined in the description, and to their use as herbicides.

  本发明涉及公式（Ia）的4-芳酰基异噁唑衍生物或公式（Ib）的2-氰基-1,3-二酮衍生物：其中R、R1、R2、X、Y和Z如描述中所定义，并且它们的用途为除草剂。
• Intramolecular diels-alder reactions of benzynes application to the total synthesis of mansonone E
  作者：Wayne M. Best、Dieter Wege

  DOI：10.1016/s0040-4039(01)92370-6

  日期：1981.1

  Substituted benzynes san be trapped intramolecularly by an attached furan moiety and such a reaction has been used in the synthesis of the naturally occurring o-naphthoquin- one mansonone E.

  取代的苯并炔分子会被附着的呋喃部分分子内捕获，并且这种反应已用于合成天然存在的邻萘甲醌一甘露酮E。
• Hanger et al., Journal of the Chemical Society, 1958, p. 496,501
  作者：Hanger et al.

  DOI：——

  日期：——
• Giencke, Astrid; Lackner, Helmut, Liebigs Annalen der Chemie, 1990, # 6, p. 569 - 579
  作者：Giencke, Astrid、Lackner, Helmut

  DOI：——

  日期：——
• Toward the Design of an RNA:DNA Hybrid Binding Agent
  作者：Wenhua Chu、Shigehiro Kamitori、Miho Shinomiya、Robert G. Carlson、Fusao Takusagawa

  DOI：10.1021/ja00085a002

  日期：1994.3

  One characteristic function of the retroviruses, which is generally not found in normal eukaryotic cells, is production of a long RNA:DNA hybrid in the viral replication phase. If agents are designed which bind only to the RNA:DNA hybrid, but neither to DNA nor to RNA, such agents will be able to inhibit specifically the RNase H activity of retroviral reverse transcriptase, and therefore will suppress viral replication. Actinomycin D binds to double-stranded DNA, but not to RNA, because steric hindrance between the 2-amino group of the phenoxazinone ring and the 2'-hydroxyl group of RNA prevents intercalation of the antibiotic. However, if the C8-H in the phenoxazinone ring is replaced by an aromatic nitrogen N8, a strong hydrogen bond acceptor, this analog (N8-actinomycin D) might be able to bind intercalatively to an RNA:DNA hybrid by forming an additional hydrogen bond between N8 and the 2'-hydroxyl group of guanosine ribose. This hypothesis has been tested by a molecular mechanics calculation using a model structure of the complex between N8-actinomycin D and a small RNA:DNA hybrid, r(GC):d(GC). The results of the molecular mechanics calculation suggest that N8-actinomycin D can intercalatively bind to the RNA: DNA hybrid by making an additional intracomplex hydrogen bond. This hydrogen bonding capability of N8 has been confirmed in the crystal structure of the chromophore of N8-actinomycin D. Thus, N8-actinomycin D has been synthesized by coupling the pyridine and benzene fragments obtained independently. A binding study indicates that both actinomycin D and N8-actinomycin D bind intercalatively not only to DNA:DNA double strands but also to RNA:DNA hybrids. Although the overall binding capacity of N8-actinomycin D is reduced substantially in comparison with that of actinomycin D itself, N8-actinomycin D tends to bind relatively more favorably than actinomycin D to the RNA:DNA hybrids. Thus, this initial attempt at designing an RNA:DNA hybrid binding agent appears to be successful. However, it is necessary to modify the agent further to increase its RNA:DNA hybrid binding character and to decrease the DNA:DNA binding character, in order to make a useful RNA:DNA hybrid binding agent.